⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIRM News
Mirum Pharmaceuticals, Inc. Common Stock
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
businesswire.com
MIRM
Form 8-K
sec.gov
MIRM
NovalGen Appoints Dr Laurent Fischer as Chair of the Board
globenewswire.com
ATAI
MIRM
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
MIRM
Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes
businesswire.com
MIRM
Form 8-K
sec.gov
MIRM
Form 8-K
sec.gov
MIRM
Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis
businesswire.com
MIRM
Form 8-K
sec.gov
MIRM
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
businesswire.com
MIRM